Drug intelligence / Profile preview

Qingyi No. 4 Compound

Development stage: Unknown
Lead developer: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Qingyi No. 4 Compound is a Traditional Chinese Medicine (TCM) formulation developed by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is specifically investigated for the treatment of patients in the convalescence phase of COVID-19 (Novel Coronavirus Pneumonia). As a compound TCM preparation, it is designed to address lingering symptoms and promote recovery following acute infection. The formulation likely exerts its therapeutic effects through multi-target immunomodulatory and anti-inflammatory pathways, which are characteristic of traditional herbal treatments for respiratory recovery.

Brand names: Qingyi No. 4 compound
Other names: Qingyi No. 4Qingyi Formula 4

Targets

BAX (Apoptosis regulator BAX)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)IL-2 (Interleukin 2)CASP3 (Caspase-3)

Beyond the preview

Go deeper on Qingyi No. 4 Compound.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingyi No. 4 Compound.

Explore the full profile